Summary
- Current Price
- As of today, JSPR price is $16.86, up +19.83% on
- Current Price All-Time High
- JSPR price is currently -99.70% below its historical high of $5,664.00 set on
- Market Cap
- JSPR current market cap is $19M, down -62.46% year-over-year
- Revenue
- JSPR current annual revenue is $0.00, unchanged year-over-year
- Next Earnings
- The next earnings release for JSPR is on
Profile
| Metric | Value |
|---|---|
| Full Name | Jasper Therapeutics, Inc. |
| Ticker | NASDAQ: JSPR |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | jaspertx.com |
| Employees | 64 |
Key Metrics
| Metric | Value | Date |
|---|---|---|
| $16.86 | ||
| Price, 1D Change | +19.83% | |
| $19M | ||
| - | ||
| - | ||
| 1.73 | ||
| $0.00 | ||
| Revenue, 1Y Change | 0.00% | |
| -$118.64 | ||
| EPS, 1Y Change | +19.07% |
Chart
SUGGESTED SERIES
Events
| Metric | Value | Date |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | 1:30 | |
| Next Split | N/A | N/A |
| Last Ticker Change | AMHC | |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Value | Date |
|---|---|---|
| -$118.64 | ||
| EPS Estimate | -$6.90 | N/A |
| EPS Est. Change | +94.18% | N/A |
| $0.00 | ||
| Revenue Estimate | $6.00M | N/A |
| Revenue Est. Change | - | N/A |
| $16.86 | ||
| Price Target | $600.00 | - |
| Price Tgt. Change | +3,458.72% | - |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| - | -$146.60 | - | |
| - | -$118.64 | - | |
| -$6.90 | N/A | +94.18% | |
| -$21.15 | N/A | +82.17% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| - | $0.00 | - | |
| - | $0.00 | - | |
| $6.00M | N/A | - | |
| - | N/A | - |
🔒 Log In To Unlock Full Data
Performance
| Metric | Value | Date |
|---|---|---|
| -68.43% | ||
| -92.37% | ||
| -62.46% | ||
| -77.11% | ||
| 0.00% | ||
| 0.00% | ||
| +19.07% | ||
| +61.72% |
🔒 Log In To Unlock Full Data
Technicals
| Metric | Value | Date |
|---|---|---|
| $16.86 | ||
| $24.78 | ||
| $17.43 | ||
| $34.53 | ||
| $17.07 | ||
| -$0.54 | ||
| 1.73 | ||
| $1.84 | ||
| 54.06 | ||
| 124.47% |
Dividends
| Metric | Value | Date |
|---|---|---|
| - | N/A | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Value | Date |
|---|---|---|
| $0.00 | ||
| -$118.64 | ||
| -$1.06M | ||
| - | ||
| -$80.52M | ||
| - | ||
| -$75.80M | ||
| - | ||
| -$79.46M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Value | Date |
|---|---|---|
| 0.30 | ||
| 2.62 | ||
| 2.62 | ||
| - | ||
| - | ||
| -18.72 |
Valuations
| Metric | Value | Date |
|---|---|---|
| - | ||
| - | ||
| 13.23 | ||
| -0.22 | ||
| - | N/A |
Balance Sheet
| Metric | Value | Date |
|---|---|---|
| $4.15M | ||
| $28.69M | ||
| $35.78M | ||
| $34.65M | ||
| $29.36M | ||
| $13.20M | ||
| $1.24M | ||
| $1.24M | ||
| $6.22M |
Expenses
| Metric | Value | Date |
|---|---|---|
| $75.80M | ||
| $79.46M | ||
| $1.06M | ||
| $0.00 | ||
| $1.06M | ||
| $0.00 | ||
| $0.00 |
Cash Flow
| Metric | Value | Date |
|---|---|---|
| -$77.16M | ||
| $5,000.00 | ||
| $34.21M | ||
| $7,000.00 | ||
| -$77.17M |
Recent analyst updates
| Metric | Value | Date |
|---|---|---|
| Piper Sandler | ||
| TD Cowen | → | |
| RBC Capital | → | |
| Evercore ISI Group | → | |
| RBC Capital | → | |
| JMP Securities | → | |
| Evercore ISI Group | → | |
| BTIG | → | |
| UBS | → | |
| JMP Securities | → |
Analyst sentiment
Institutional ownership
No data
Screeners with JSPR
FAQ
- What is the ticker symbol for Jasper Therapeutics, Inc.?
- The ticker symbol for Jasper Therapeutics, Inc. is NASDAQ:JSPR
- Does Jasper Therapeutics, Inc. pay dividends?
- No, Jasper Therapeutics, Inc. does not pay dividends
- What sector is Jasper Therapeutics, Inc. in?
- Jasper Therapeutics, Inc. is in the Healthcare sector
- What industry is Jasper Therapeutics, Inc. in?
- Jasper Therapeutics, Inc. is in the Biotechnology industry
- What country is Jasper Therapeutics, Inc. based in?
- Jasper Therapeutics, Inc. is headquartered in United States
- When did Jasper Therapeutics, Inc. go public?
- Jasper Therapeutics, Inc. initial public offering (IPO) was on January 10, 2020
- Is Jasper Therapeutics, Inc. in the S&P 500?
- No, Jasper Therapeutics, Inc. is not included in the S&P 500 index
- Is Jasper Therapeutics, Inc. in the NASDAQ 100?
- No, Jasper Therapeutics, Inc. is not included in the NASDAQ 100 index
- Is Jasper Therapeutics, Inc. in the Dow Jones?
- No, Jasper Therapeutics, Inc. is not included in the Dow Jones index
- When was Jasper Therapeutics, Inc. last earnings report?
- Jasper Therapeutics, Inc.'s most recent earnings report was on August 14, 2026
- When does Jasper Therapeutics, Inc. report earnings?
- The next expected earnings date for Jasper Therapeutics, Inc. is November 10, 2026
Data Sources & References
- JSPR Official Website jaspertx.com
- JSPR Profile on Yahoo Finance finance.yahoo.com/quote/JSPR
- JSPR Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/jspr